Exchange Capital Management Inc. increased its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 16.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,157 shares of the company’s stock after purchasing an additional 878 shares during the quarter. Exchange Capital Management Inc.’s holdings in Clorox were worth $1,000,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Wealth Group Ltd. bought a new stake in Clorox in the third quarter valued at approximately $231,000. Blue Trust Inc. raised its holdings in shares of Clorox by 34.7% during the third quarter. Blue Trust Inc. now owns 913 shares of the company’s stock worth $149,000 after acquiring an additional 235 shares during the period. Hennion & Walsh Asset Management Inc. acquired a new position in Clorox in the 3rd quarter worth $395,000. Ballentine Partners LLC raised its position in Clorox by 13.2% in the 3rd quarter. Ballentine Partners LLC now owns 2,474 shares of the company’s stock valued at $403,000 after buying an additional 288 shares during the last quarter. Finally, Allworth Financial LP increased its stake in Clorox by 35.2% in the 3rd quarter. Allworth Financial LP now owns 7,364 shares of the company’s stock valued at $1,200,000 after buying an additional 1,917 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
CLX has been the topic of a number of recent analyst reports. Wells Fargo & Company boosted their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Barclays increased their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $158.21.
Clorox Stock Down 1.7 %
NYSE CLX opened at $154.52 on Tuesday. The company has a market capitalization of $19.03 billion, a P/E ratio of 42.22, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock’s 50-day moving average price is $157.53 and its 200-day moving average price is $160.03. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the company posted $2.16 earnings per share. On average, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Manufacturing Stocks Investing
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Why Are These Companies Considered Blue Chips?
- Price Targets on NVIDIA Rise in Front of Earnings
- What is the FTSE 100 index?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.